MyMSTeam

Fatty liver isn't a direct symptom of MS, but there are some important connections worth knowing about, especially when it comes to MS treatments and certain comorbidities.

Some disease-modifying therapies (DMTs) used to treat MS can affect liver function. These include:

- Alemtuzumab (Lemtrada)
- Fingolimod (Gilenya)
- Show Full Answer

Fatty liver isn't a direct symptom of MS, but there are some important connections worth knowing about, especially when it comes to MS treatments and certain comorbidities.

Some disease-modifying therapies (DMTs) used to treat MS can affect liver function. These include:

- Alemtuzumab (Lemtrada)
- Fingolimod (Gilenya)
- Interferon-beta
- Natalizumab (Tysabri)
- Ocrelizumab (Ocrevus)

If you're on any of these medications, your doctor will likely monitor your liver through regular blood tests to catch any issues early. Diet can also play a role in liver health. High saturated fat intake is associated with inflammation, which is already a concern for people with MS. Eating a diet lower in saturated fats and higher in vegetables may help support both liver and overall health.

It's always best to flag any liver concerns with your neurologist, especially if you're currently on a DMT. They can run blood tests and advise on the best path forward for your specific situation. 🙂

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Does MS Affect the Liver, Kidneys, or Spleen?

Swank Diet for Relapsing MS: What You Should Know